223 related articles for article (PubMed ID: 32844174)
1. Serum Serotonin Differentiates Between Disease Activity States in Crohn's Patients.
Manzella CR; Jayawardena D; Pagani W; Li Y; Alrefai WA; Bauer J; Jung B; Weber CR; Gill RK
Inflamm Bowel Dis; 2020 Sep; 26(10):1607-1618. PubMed ID: 32844174
[TBL] [Abstract][Full Text] [Related]
2. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
[TBL] [Abstract][Full Text] [Related]
3. The serotonin reuptake transporter is reduced in the epithelium of active Crohn's disease and ulcerative colitis.
Jørandli JW; Thorsvik S; Skovdahl HK; Kornfeld B; Sæterstad S; Gustafsson BI; Sandvik AK; van Beelen Granlund A
Am J Physiol Gastrointest Liver Physiol; 2020 Dec; 319(6):G761-G768. PubMed ID: 32967429
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
5. ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides.
Hu X; Deng J; Yu T; Chen S; Ge Y; Zhou Z; Guo Y; Ying H; Zhai Q; Chen Y; Yuan F; Niu Y; Shu W; Chen H; Ma C; Liu Z; Guo F
Gastroenterology; 2019 Mar; 156(4):1098-1111. PubMed ID: 30452920
[TBL] [Abstract][Full Text] [Related]
6. Identification of pathologic features associated with "ulcerative colitis-like" Crohn's disease.
James SD; Wise PE; Zuluaga-Toro T; Schwartz DA; Washington MK; Shi C
World J Gastroenterol; 2014 Sep; 20(36):13139-45. PubMed ID: 25278708
[TBL] [Abstract][Full Text] [Related]
7. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
[TBL] [Abstract][Full Text] [Related]
8. Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease.
Mitsialis V; Wall S; Liu P; Ordovas-Montanes J; Parmet T; Vukovic M; Spencer D; Field M; McCourt C; Toothaker J; Bousvaros A; ; ; Shalek AK; Kean L; Horwitz B; Goldsmith J; Tseng G; Snapper SB; Konnikova L
Gastroenterology; 2020 Aug; 159(2):591-608.e10. PubMed ID: 32428507
[TBL] [Abstract][Full Text] [Related]
9. Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease.
Kader HA; Tchernev VT; Satyaraj E; Lejnine S; Kotler G; Kingsmore SF; Patel DD
Am J Gastroenterol; 2005 Feb; 100(2):414-23. PubMed ID: 15667502
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease.
Weigert J; Obermeier F; Neumeier M; Wanninger J; Filarsky M; Bauer S; Aslanidis C; Rogler G; Ott C; Schäffler A; Schölmerich J; Buechler C
Inflamm Bowel Dis; 2010 Apr; 16(4):630-7. PubMed ID: 19714754
[TBL] [Abstract][Full Text] [Related]
11. Serum adipokines in inflammatory bowel disease.
Waluga M; Hartleb M; Boryczka G; Kukla M; Zwirska-Korczala K
World J Gastroenterol; 2014 Jun; 20(22):6912-7. PubMed ID: 24944482
[TBL] [Abstract][Full Text] [Related]
12. Predicting Mucosal Healing in Crohn's Disease Using Practical Clinical Indices with Regard to the Location of Active Disease.
Bamba S; Tsujikawa T; Ban H; Imaeda H; Inatomi O; Nishida A; Sasaki M; Andoh A; Fujiyama Y
Hepatogastroenterology; 2014 May; 61(131):689-96. PubMed ID: 26176058
[TBL] [Abstract][Full Text] [Related]
13. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-320a Monitors Intestinal Disease Activity in Patients With Inflammatory Bowel Disease.
Cordes F; Demmig C; Bokemeyer A; Brückner M; Lenze F; Lenz P; Nowacki T; Tepasse P; Schmidt HH; Schmidt MA; Cichon C; Bettenworth D
Clin Transl Gastroenterol; 2020 Mar; 11(3):e00134. PubMed ID: 32352717
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Serum Calprotectin Levels in Patients with Inflammatory Bowel Disease.
Mori A; Mitsuyama K; Sakemi R; Yoshioka S; Fukunaga S; Kuwaki K; Yamauchi R; Araki T; Yoshimura T; Yamasaki H; Tsuruta K; Morita T; Yamasaki S; Tsuruta O; Torimura T
Kurume Med J; 2021 Dec; 66(4):209-215. PubMed ID: 34690210
[TBL] [Abstract][Full Text] [Related]
16. Serum Interleukin-33 level in Saudi children with inflammatory bowel disease.
Saadah OI; Al-Harthi SE; Al-Mughales JA; Bin-Taleb YY; Baeshen RS
Int J Clin Exp Pathol; 2015; 8(12):16000-6. PubMed ID: 26884875
[TBL] [Abstract][Full Text] [Related]
17. High circulating elafin levels are associated with Crohn's disease-associated intestinal strictures.
Wang J; Ortiz C; Fontenot L; Xie Y; Ho W; Mattai SA; Shih DQ; Koon HW
PLoS One; 2020; 15(4):e0231796. PubMed ID: 32287314
[TBL] [Abstract][Full Text] [Related]
18. The utility of apoptosis inhibitor of macrophages as a possible diagnostic marker in patients with Crohn's disease.
Ono Y; Kanmura S; Morinaga Y; Oda K; Kawabata K; Arima S; Sasaki F; Nasu Y; Tanoue S; Hashimoto S; Taguchi H; Uto H; Tsubouchi H; Ido A
BMC Gastroenterol; 2017 Mar; 17(1):40. PubMed ID: 28284201
[TBL] [Abstract][Full Text] [Related]
19. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
[TBL] [Abstract][Full Text] [Related]
20. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]